Benzinga | Apr 28, 2021 04:33PM EDT

Viking Therapeutics Q1 EPS $(0.19) Misses $(0.17) Estimate

Viking Therapeutics (NASDAQ:VKTX) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.17) by 11.76 percent. This is a 46.15 percent decrease over losses of $(0.13) per share from the same period last year.